Longitudinal GBM biopsies uncovered effects of immunotherapy that could not be surmised by routine MRI or clinical analyses.

Physics-based ML framework designs IDPs—biomolecules without fixed structures that underlie key functions and diseases such as Parkinson’s.

In both cases, the partners aim to help scientists automate and streamline their genomics workflows in disease research and drug development.

Whole process simulation method gives drug firms more information about process equipment-related leachables—PERLs, say developers.

A new study presents computational strategies to manipulate membrane protein folding and function for biotechnological applications.

Continuous hyperosmotic pressure enhances specific cell productivity and reduces hypoxia in perfusion cultures.

Using NISTCHO means people can test the reproducibility of experiments in different labs and with different off-the-shelf media.

The 2025 Nobel Prize in Chemistry honors the creators of metal-organic frameworks—porous, flexible materials with a vast range of applications.

Angelica Meyer highlights downstream bioprocessing challenges, emphasizing quality, innovation, and advancing transformative therapies.

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

This year’s A-List shows that the revenues for the top five public companies in spatial biology have risen nine percent from a year ago ...

To explore the latest breakthroughs in proteomics, GEN spoke with five companies at the forefront of proteomic innovation.